col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: European Journal of Medicinal Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―23 In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease Muya Xiong, Tianqing Nie, Qiang Shao, Minjun Li, Haixia Su, Yechun Xu
2 [GO] 2022―Jan―13 Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition Vanna Sanna, Sandro Satta, Tzung Hsiai, Mario Sechi
3 [GO] 2021―Dec―11 Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors Julia K. Stille, Jevgenijs Tjutrins, Guanyu Wang, Felipe A. Venegas, Christopher Hennecker, Andrés M. Rueda, et al. (+14)
4 [GO] 2021―Dec―01 Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19 Jian-Wei Zhang, Yuan Xiong, Feng Wang, Fu-Mao Zhang, Xiaodi Yang, Guo-Qiang Lin, et al. (+3)
5 [GO] 2021―Nov―01 Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2 Yi-Ting Wang, Xin-Yan Long, Xiao Ding, Shi-Rui Fan, Jie-Yun Cai, Bi-Juan Yang, et al. (+9)
6 [GO] 2021―Oct―05 Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19 Le-le Ma, Hui-min Liu, Xue-mei Liu, Xiao-yu Yuan, Chao Xu, Fang Wang, et al. (+3)
7 [GO] 2021―Sep―22 Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization Veronica Di Sarno, Gianluigi Lauro, Simona Musella, Tania Ciaglia, Vincenzo Vestuto, Marina Sala, et al. (+13)
8 [GO] 2021―Sep―21 Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus Naglaa Salem El-Sayed, Alexander S. Jureka, Megan R. Edwards, Sandeep Lohan, Caroline G. Williams, Patrick T. Keiser, et al. (+5)
9 [GO] 2021―Aug―18 Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors Jiahua Cui, Jinping Jia
10 [GO] 2021―Jul―05 System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 Ilaria Vicenti, Maria Grazia Martina, Adele Boccuto, Marta De Angelis, Giorgia Giavarini, Filippo Dragoni, et al. (+10)
11 [GO] 2021―Jun―10 Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors Guo-Ning Zhang, Jianyuan Zhao, Quanjie Li, Minghua Wang, Mei Zhu, Juxian Wang, et al. (+2)
12 [GO] 2021―May―30 Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: structural enhancements, increased solubility, and micellar studies Wayne Vuong, Conrad Fischer, Muhammad Bashir Khan, Marco J. van Belkum, Tess Lamer, Kurtis D. Willoughby, et al. (+10)
13 [GO] 2021―May―05 A Cyclic Peptide Inhibitor of the SARS-CoV-2 Main Protease Adam G. Kreutzer, Maj Krumberger, Elizabeth M. Diessner, Chelsea Marie T. Parrocha, Michael A. Morris, Gretchen Guaglianone, et al. (+2)
14 [GO] 2021―Mar―20 Structure-Based Drug Design of an Inhibitor of the SARS-CoV-2 (COVID-19) Main Protease Using Free Software: A Tutorial for Students and Scientists Sheng Zhang, Maj Krumberger, Michael A. Morris, Chelsea Marie T. Parrocha, Adam G. Kreutzer, James S. Nowick
15 [GO] 2021―Feb―15 Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors? Sk. Abdul Amin, Suvankar Banerjee, Shovanlal Gayen, Tarun Jha
16 [GO] 2021―Feb―09 Discovery and Structural Optimization of 3-O-β-Chacotriosyl Oleanane-type Triterpenoids as Potent Entry Inhibitors of SARS-CoV-2 Virus Infections Hui Li, Chen Cheng, Sumei Li, Yan Wu, Zhihao Liu, Mingjian Liu, et al. (+5)
17 [GO] 2021―Jan―22 RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic Lei Tian, Taotao Qiang, Chengyuan Liang, Xiaodong Ren, Minyi Jia, Jiayun Zhang, et al. (+6)
18 [GO] 2021―Jan―13 The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2 Irshad Ahmad
19 [GO] 2020―Sep―19 Primed for Global Coronavirus Pandemic: Emerging Research and Clinical Outcome Shakir Ahamad, Scotty Branch, Shea Harrelson, Mohd Kamil Hussain, Mohammad Saquib, Saeed Khan
20 [GO] 2020―Aug―06 The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020 Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaodong Ren, Lei Tian, Xingke Ju, et al. (+9)
21 [GO] 2020―Aug―01 Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds Pei Liu, Hongbo Liu, Qi Sun, Hao Liang, Chunmei Li, Xiaobing Deng, et al. (+2)
22 [GO] 2020―Jul―28 Potential treatment methods targeting 2019-nCoV infection Lu Zheng, Lina Zhang, Jiamin Huang, Kutty Selva Nandakumar, Shuwen Liu, Kui Cheng
23 [GO] 2020―Jul―15 COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus Vladimir V. Kouznetsov
24 [GO] 2020―Jul―15 Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses Canan G. Nebigil, Christiane Moog, Stéphan Vagner, Nadia Benkirane-Jessel, Duncan R. Smith, Laurent Désaubry
25 [GO] 2020―Jun―12 Fight against novel coronavirus: A perspective of medicinal chemists Sk. Abdul Amin, Tarun Jha
26 [GO] 2020―Jun―12 Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase Rostom Ahmed-Belkacem, Priscila Sutto-Ortiz, Mathis Guiraud, Bruno Canard, Jean-Jacques Vasseur, Etienne Decroly, Françoise Debart
27 [GO] 2020―Jun―06 A Promising Antiviral Candidate Drug for the COVID-19 Pandemic: A Mini-Review of Remdesivir Chengyuan Liang, Lei Tian, Yuzhi Liu, Nan Hui, Guaiping Qiao, Han Li, et al. (+5)


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.011 sec